Overview
Chiara Lambertini practices practicing medicine in Basel, Switzerland.
Ms. Lambertini is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum and Breast Cancer.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chiara Lambertini
Is Chiara Lambertini a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Chiara Lambertini is classified as an Advanced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chiara Lambertini participate in research or clinical trials?
Yes. Chiara Lambertini has published 11 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Chiara Lambertini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMs. Lambertini isAdvanced. Learn about Breast Cancer.
- PIK3CA-Related Overgrowth SpectrumMs. Lambertini isAdvanced. Learn about PIK3CA-Related Overgrowth Spectrum.